Poliskiĭ N M, Berger E I, Kotliarskaia L A, Voskoboĭnik L E, Kisel' S S
Kardiologiia. 1979 Jul;19(7):59-62.
The antiarrhythmic effect of triamecain (mesocain) was studied in 104 patients with acute or chronic form of ischemic heart disease during 169 episodes of disorder of cardiac activity rhythm. It is shown that trimecain possesses marked antiarrhythmic activity manifested in disorders of automaticity and excitability as well as in cardiac fibrillation. Intolerance to the drug was a relatively rare occurrence.
在104例患有急性或慢性缺血性心脏病的患者中，对169次心律失常发作期间的三甲卡因（美索卡因）抗心律失常作用进行了研究。结果表明，三甲卡因具有显著的抗心律失常活性，表现在自律性和兴奋性紊乱以及房颤方面。对该药物的不耐受情况相对少见。
